ClinicalTrials.Veeva

Menu

Hemodynamic Evaluation Using Microcirculation for Early Treatment of Septic Patients (HEMOCAP)

U

University of Limoges (UL)

Status

Enrolling

Conditions

Emergency Care
Microcirculation
Sepsis

Treatments

Diagnostic Test: measurement of the peripheral perfusion index and marbling assessment

Study type

Interventional

Funder types

Other

Identifiers

NCT06910891
87RI24_0047 (HEMOCAP
2025-A00216-43 (Other Identifier)

Details and patient eligibility

About

Despite early treatment, the deterioration and mortality of sepsis patients remains high. A possible explanation could be persistent tissue hypoperfusion, or undetected in the early phase despite the normalization of macro-hemodynamic parameters. This interventional study evaluates the impact of measuring microcirculation parameters by nurses on patient prognosis through early initiation of vascular filling.

Full description

Sepsis and its most serious form, septic shock, are a public health problem. Sepsis is defined by the presence of organ failure, including acute circulatory failure, which combines hypovolemia, vasoplegia and cardiac dysfunction. Vascular filling is therefore a pillar of the management of septic patients to correct hypovolemia and improve perfusion and tissue oxygenation. Following numerous studies, the evaluation of peripheral microcirculation is becoming a clinical "trigger" making it possible to identify patients at risk, particularly in emergency department. In a meta-analysis, it has been showed that alterations in microcirculatory perfusion predict deterioration and mortality during severe infections. Currently, no interventional study has evaluated the impact of measuring microcirculatory perfusion (peripheral perfusion index and marbling) by nurses on patient prognosis through early initiation of vascular filling.

In this study, patients will be assessed hemodynamically using peripheral perfusion index and/or presence of mottling. If peripheral perfusion index > 3s and/or presence of marbling a first vascular filling test of 500 cc over 30 minutes will be started after a medical control.

Patient will be followed up 7 days to determine outcome.

Enrollment

556 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥ 18 years
  2. Admitted to the Emergency Department for suspected Sepsis for less than 6 hours according to international Sepsis-3 definitions (high probability of infection defined by a fever greater than or equal tol to 38.3°C with a suspected infectious source + Score NEWS 2 greater than or equal to 2)
  3. Affiliated to a social security system
  4. Having agreed to participate in this study

Exclusion criteria

  1. Patient with arterial hypotension (SBP ≤ 100 mmHg) on admission
  2. Patient having already received a 500mL filling test over 30 minutes
  3. Patients moribund according to the investigator
  4. Pregnancy or breastfeeding
  5. Patient under guardianship, curatorship or safeguard of justice

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

556 participants in 2 patient groups

Intervention arm
Experimental group
Description:
As soon as an eligible patient is identified by the nurse, in addition to the classic hemodynamic parameters measured in all patients, a measurement of the peripheral perfusion index (from 1 sec to 10 sec) and marbling assessment (scale from 0 to 5) will be performed. This measurement will be validated by the senior doctor of the Sepsis Department. When the peripheral perfusion index will be ≥ 3 sec and/or the marbling score ≥ 1, a first vascular filling test of 500 cc over 30 minutes will be started, regardless of the value of the hemodynamic parameters.
Treatment:
Diagnostic Test: measurement of the peripheral perfusion index and marbling assessment
Control arm
No Intervention group
Description:
Patients will benefit from treatment according to current standards of care

Trial contacts and locations

6

Loading...

Central trial contact

Anaelle NARDOT-SUCHAUD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems